A14 Arginine methylation of huntingtin is a novel post-translational modification that impacts huntington's disease pathogenesis. (September 2018)
- Record Type:
- Journal Article
- Title:
- A14 Arginine methylation of huntingtin is a novel post-translational modification that impacts huntington's disease pathogenesis. (September 2018)
- Main Title:
- A14 Arginine methylation of huntingtin is a novel post-translational modification that impacts huntington's disease pathogenesis
- Authors:
- Migazzi, Alice
Tripathy, Debasmita
Scaramuzzino, Chiara
Pandey, Udai Bhan
Saudou, Frédéric
Pennuto, Maria
Basso, Manuela - Abstract:
- Abstract : Background: Huntington's disease (HD) is a fatal neurodegenerative disorder characterized by the loss of striatal and cortical neurons. HD is caused by an abnormal polyglutamine (polyQ) expansion in huntingtin protein (HTT). Arginine methylation is a post-translational modification (PTM) catalyzed by protein arginine methyltransferases (PRMTs) with a key role in the pathogenesis of polyglutamine diseases. However, its role in HD remains to be elucidated. Aims: The aim of our work is to understand whether HTT is methylated by PRMTs and how this PTM affects the toxicity of mutant HTT. Methods: We analyzed arginine methylation of HTT by mass spectrometry of mouse brain extracts and in vitro methylation assays. The interaction of wild-type or polyQ-HTT with PRMTs was investigated through immunoprecipitation and proximity ligation assay in immortalized striatal cells. Finally, we undertook a loss-of-function and gain-of-function approach both in vitro and in vivo to assess the role of PRMTs and arginine methylation in HD. Results: We found that HTT is methylated at specific arginine residues in the brain of normal mice. HTT colocalizes and forms a complex with specific members of the PRMT family. Importantly, the polyglutamine expansion in HTT reduces the interaction with the PRMTs. Loss of PRMT function in striatal cells expressing polyQ-HTT exacerbates toxicity, and the expression of a methylation-defective mutant of HTT decreases the survival of primary corticalAbstract : Background: Huntington's disease (HD) is a fatal neurodegenerative disorder characterized by the loss of striatal and cortical neurons. HD is caused by an abnormal polyglutamine (polyQ) expansion in huntingtin protein (HTT). Arginine methylation is a post-translational modification (PTM) catalyzed by protein arginine methyltransferases (PRMTs) with a key role in the pathogenesis of polyglutamine diseases. However, its role in HD remains to be elucidated. Aims: The aim of our work is to understand whether HTT is methylated by PRMTs and how this PTM affects the toxicity of mutant HTT. Methods: We analyzed arginine methylation of HTT by mass spectrometry of mouse brain extracts and in vitro methylation assays. The interaction of wild-type or polyQ-HTT with PRMTs was investigated through immunoprecipitation and proximity ligation assay in immortalized striatal cells. Finally, we undertook a loss-of-function and gain-of-function approach both in vitro and in vivo to assess the role of PRMTs and arginine methylation in HD. Results: We found that HTT is methylated at specific arginine residues in the brain of normal mice. HTT colocalizes and forms a complex with specific members of the PRMT family. Importantly, the polyglutamine expansion in HTT reduces the interaction with the PRMTs. Loss of PRMT function in striatal cells expressing polyQ-HTT exacerbates toxicity, and the expression of a methylation-defective mutant of HTT decreases the survival of primary cortical neurons. Conversely, gain of PRMT function attenuates striatal cell death and suppresses polyQ-HTT-mediated lethality in HD flies. Conclusions: These results suggest that arginine methylation plays a key role in HD pathogenesis. Particularly, PRMT-mediated arginine methylation of HTT is protective in HD. … (more)
- Is Part Of:
- Journal of neurology, neurosurgery and psychiatry. Volume 89(2018)Supplement 1
- Journal:
- Journal of neurology, neurosurgery and psychiatry
- Issue:
- Volume 89(2018)Supplement 1
- Issue Display:
- Volume 89, Issue 1 (2018)
- Year:
- 2018
- Volume:
- 89
- Issue:
- 1
- Issue Sort Value:
- 2018-0089-0001-0000
- Page Start:
- A5
- Page End:
- A6
- Publication Date:
- 2018-09
- Subjects:
- Arginine methylation -- huntingtin -- post-translational modification
Neurology -- Periodicals
Nervous system -- Surgery -- Periodicals
Psychiatry -- Periodicals
616.8 - Journal URLs:
- http://jnnp.bmjjournals.com/ ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?action=archive&journal=192 ↗
http://www.bmj.com/archive ↗ - DOI:
- 10.1136/jnnp-2018-EHDN.14 ↗
- Languages:
- English
- ISSNs:
- 0022-3050
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 18783.xml